Merck Will Apply Biocatalyst Technology To Its Pipeline Under Deal With Codexis
This article was originally published in The Pink Sheet Daily
Access to Codex Biocatalyst Panels can be used by drug makers to make chemical manufacturing processes faster and more environmentally friendly.
You may also be interested in...
The ADC specialist could have a fourth cancer drug on the market this year and is preparing for its first commercial launch in Europe.
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.